⌘K
t
GlaxoSmithKline plc announced on 20 September 2021 that Dr Vivienne Cox CBE, a Non-Executive Director, has been appointed to roles at Victrex plc. Dr Cox will become a non-executive director of Victrex plc from 1 December 2021, Chair-designate from 1 January 2022, and assume responsibility as Chair from 11 February 2022.
| Date | 20 Sept 2021 |
| Time | 14:42:16 |
| Category | Miscellaneous |
| ID | 3494M |
GlaxoSmithKline plc
Director Declaration
GlaxoSmithKline plc announces, pursuant to the Financial Conduct Authority's Listing Rule 9.6.14(2), that Dr Vivienne Cox CBE, Non-Executive Director, has been appointed as a non-executive director and Chair-designate of Victrex plc with effect from 1 December 2021 and 1 January 2022 respectively. Dr Cox will assume responsibility as Chair of Victrex plc with effect from 11 February 2022.
V A Whyte
Company Secretary
20 September 2021